cangrelor and Chest-Pain

cangrelor has been researched along with Chest-Pain* in 1 studies

Other Studies

1 other study(ies) available for cangrelor and Chest-Pain

Article	Year
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty. Journal of cardiovascular medicine (Hagerstown, Md.), 2021, 04-01, Volume: 22, Issue:4 Topics: Adenosine Monophosphate; Aged; Anxiety; Chest Pain; Coronary Angiography; Coronary Occlusion; Drug Substitution; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Electrocardiography; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Withholding Treatment	2021

Article

Year

Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty.

Journal of cardiovascular medicine (Hagerstown, Md.), 2021, 04-01, Volume: 22, Issue:4

Topics: Adenosine Monophosphate; Aged; Anxiety; Chest Pain; Coronary Angiography; Coronary Occlusion; Drug Substitution; Drug-Eluting Stents; Drug-Related Side Effects and Adverse Reactions; Dyspnea; Electrocardiography; Humans; Inferior Wall Myocardial Infarction; Male; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Withholding Treatment

2021